GPX4 and breast carcinoma: Moreover, compounds 78 (5 μM), 76 (10 μM), and more effectively the conjugate 77 (2 μM) elevated MDA levels and decreased GPX4 expression in human HCT116 CRCs282 or in human MCF‐7 breast cancer cells.281